glp-1 receptor agonists side effects Gastrointestinal effect and adverse of agonist GLP-1 Receptor Agonists: From Diabetes
Description
doi: 10.1080/14728214.2021.1947240
The disease spectrum of MASLD ranges from benign hepatic steatosis to more severe forms, including metabolic steatohepatitis (MASH), which can progress to liver fibrosis, cirrhosis, and ultimately, liver failure
Barriers to Injectable GLP-1 RA Therapy Quite a few barriers have been identified related to injectable GLP-1 RA therapy
Four RCT studies including 12,480 patients provided information on the use of Dulaglutide and the risk of respiratory disease
A synthetic version of one of the peptides found in their venom is used in the painkilling drug ziconotide
